[Stabilizing effect of anti-inflammatory drugs on erythrocyte membrane. II. On UV-induced canine erythrocyte hemolysisand lipid peroxidation, on UV-induced peroxide formation in extracted lipid, and on irradiated lipid-induced hemolysis].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001623:Betamethasone / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects / Q000528:radiation effects; D002738:Chloroquine / Q000494:pharmacology; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects* / Q000528:radiation effects; D005260:Female; D005439:Flufenamic Acid / Q000494:pharmacology; D006168:Guinea Pigs; D006461:Hemolysis / Q000187:drug effects* / Q000528:radiation effects; D050356:Lipid Metabolism; D008055:Lipids / Q000032:analysis / Q000494:pharmacology / Q000528:radiation effects; D008528:Mefenamic Acid / Q000494:pharmacology; D010113:Oxyphenbutazone / Q000494:pharmacology; D010545:Peroxides / Q000096:biosynthesis; D010653:Phenylbutazone / Q000494:pharmacology; D011239:Prednisolone / Q000494:pharmacology; D011830:Radiation Effects; D012459:Salicylates / Q000494:pharmacology; D014466:Ultraviolet Rays
D000893:Anti-Inflammatory Agents; D008055:Lipids; D010545:Peroxides; D012459:Salicylates; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D002738:Chloroquine; D001623:Betamethasone; D011239:Prednisolone; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin